SCHEMBL29997473

SCHEMBL29997473

CC(C)(C)OC(=O)N1CCCCC(=O)/C1=C\c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ ACHE P22303 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.38
▸ HDAC1 Q13547 2/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ KDM1A O60341 1/20 0.37
▸ MITF O75030 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14358003 0.84 MEN1 (0.38) ALDH1A1HTTHDAC1SMN1; SMN2MEN1
SCHEMBL5447566 0.84 MEN1 (0.38) ALDH1A1HTTHDAC1SMN1; SMN2MEN1
SCHEMBL11079589 0.79 MAPK1 (0.44) ALDH1A1NFKB1NFKB2RELAGPR119
SCHEMBL11078866 0.74 HDAC1 (0.44) ALDH1A1HTTTSHRNFKB1NFKB2
SCHEMBL25625337 0.72 MAPK1 (0.50) ALDH1A1HTTTSHRALOX15ACHE
SCHEMBL5795681 0.72 NOTUM (0.57) ALDH1A1TSHRKDM1ASMN1; SMN2MEN1
SCHEMBL1473227 0.72 GPR119 (0.51) TSHRALOX15GPR119KDM4EPKM
SCHEMBL4253428 0.72 BRD4 (0.34) KDM4EKDM1ASMN1; SMN2MEN1MAPT
SCHEMBL42476 0.72 SMN1; SMN2 (0.48) ALDH1A1HDAC1HDAC6KDM4EMITF
SCHEMBL30740727 0.71 HSD11B1 (0.39) ALDH1A1HTTSMN1; SMN2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4069366-B1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI FOUNDATION INC (US) 2025-03-19 — — EP disclosed
US-11685734-B2 ATM kinase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. (US) 2023-06-27 — — US disclosed
EP-4069366-A1 ATM KINASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF CHDI Foundation, Inc. (US) 2022-10-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685734-B2 ATM kinase inhibitors and compositions and methods of use thereof ATM, CHEK2, CHEK1 ALDH1A1 4039/4885HTT 3327/4885TSHR 3766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback